V
Power Law company profile
Vanda Pharmaceuticals
Biotech & Life Sciences · Washington DC, United States · Founded 2003 · IPO 2006 Thoroughbred
Valuation
$175M
Market cap · May/2026
Revenue
$216M
Latest reported FY
Featured in
$10B+ revenueThoroughbred · Power Law outcome
Investors
2 investors on Vanda Pharmaceuticals's cap table
Sourced from Dealroom's funding history. Investor profile links are shown where available.
Series B+
2 investors entered at this stage
Global footprint
Where Vanda Pharmaceuticals has talent and traffic
Workforce by country
4
countries with
team presence
team presence
🇺🇸 United States96.3%
🇩🇪 Germany1.6%
🇬🇧 United Kingdom1%
🇫🇷 France0.3%
Web traffic by country
41K
monthly visits
across markets
across markets
🇺🇸 United States80.5%
🇬🇧 United Kingdom5.4%
🇨🇦 Canada3.9%
🏳️ Korea3.2%
🏳️ Republic of2.4%
Market sentiment
What the market is saying about Vanda Pharmaceuticals
An AI-synthesized read of the highest-engagement posts about Vanda Pharmaceuticals on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Vanda Pharmaceuticals on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.